Dermatology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Praceta Dr. Mota Pinto, Coimbra, Portugal.
Clinics of Dermatology, Faculty of Medicine of Coimbra University, Azinhaga de Santa Comba, Coimbra, Portugal.
Lasers Surg Med. 2024 Aug;56(6):564-573. doi: 10.1002/lsm.23815. Epub 2024 Jun 18.
Under optimal conditions, afferent and efferent human skin graft microcirculation can be restored 8-12 days postgrafting. Still, the evidence about the reperfusion dynamics beyond this period in a dermato-oncologic setting is scant. We aimed to characterise the reperfusion of human skin grafts over 4 weeks according to the necrosis extension (less than 20%, or 20%-50%) and anatomic location using laser speckle contrast imaging (LSCI).
Over 16 months, all eligible adults undergoing skin grafts following skin cancer removal on the scalp, face and lower limb were enroled. Perfusion was assessed with LSCI on the wound margin (control skin) on day 0 and on the graft surface on days 7, 14, 21 and 28. Graft necrosis extension was determined on day 28.
Forty-seven grafts of 47 participants were analysed. Regardless of necrosis extension, graft perfusion equalled the control skin by day 7, surpassed it by day 21, and stabilised onwards. Grafts with less than 20% necrosis on the scalp and lower limb shared this reperfusion pattern and had a consistently better-perfused centre than the periphery for the first 21 days. On the face, the graft perfusion did not differ from the control skin from day 7 onwards, and there were no differences in reperfusion within the graft during the study.
Skin graft reperfusion is a protracted process that evolves differently in the graft centre and periphery, influenced by postoperative time and anatomic location. A better knowledge of this process can potentially enhance the development of strategies to induce vessel ingrowth into tissue-engineered skin substitutes.
在最佳条件下,移植后 8-12 天可恢复传入和传出的人类皮肤移植物微循环。然而,在皮肤肿瘤学环境下,关于这一时期后再灌注动力学的证据仍然很少。我们旨在使用激光散斑对比成像(LSCI)根据坏死扩展(小于 20%,或 20%-50%)和解剖位置来描述 4 周内人类皮肤移植物的再灌注。
在 16 个月的时间里,所有符合条件的成年人在头皮、面部和下肢皮肤癌切除后接受皮肤移植都被纳入研究。在第 0 天对伤口边缘(对照皮肤)和第 7、14、21 和 28 天对移植物表面进行 LSCI 评估灌注。在第 28 天确定移植物坏死扩展。
分析了 47 名参与者的 47 个移植物。无论坏死扩展如何,移植物灌注在第 7 天等同于对照皮肤,在第 21 天超过对照皮肤,并在此后稳定下来。头皮和下肢坏死小于 20%的移植物具有相同的再灌注模式,在前 21 天,中心的灌注始终比周边好。在面部,移植物灌注从第 7 天开始与对照皮肤无差异,并且在研究期间移植物内的再灌注没有差异。
皮肤移植物再灌注是一个漫长的过程,受术后时间和解剖位置的影响,在移植物中心和周边的演变方式不同。对这一过程的更好了解,可能会增强诱导血管向组织工程化皮肤替代物中生长的策略的开发。